Despite substantial efforts during the COVID-19 pandemic, significant gaps remain in the ability to rapidly scale up a medical countermeasure (MCM) response to public health emergencies (PHEs) in the United States. The need to create and sustain vital infrastructure to rapidly conduct multicenter clinical research in emergencies is ever present as global infectious disease emergencies continue. The overarching objectives of this consortium of clinical networks are to improve outcomes during emergencies by developing and deploying mechanisms for rapid assessment of target populations for clinical trials, rapid data collection, analysis, and dissemination of findings in diverse communities.
